Furthermore, our study revealed that high PUS7 expression is markedly associated with poor prognosis, enhanced tumour stemness, and reduced immune infiltration, indicating that PUS7 may drive pancreatic cancer progression through modulation of the immune microenvironment. The gene discussed is PUS7; the disease is neoplasm.